CD56/neural cell adhesion molecule expression in primary extranodal Ki- 1/CD30+ lymphoma: Report of a pediatric case with simultaneous cutaneous and bone localizations

American Journal of Dermatopathology

Volumn 19, Issue 4, 1997, Pages 384-390

  Paulli, Marco ^a,c   Boveri, Emanuela ^a   Rosso, Renato ^a   Aricò, Maurizio ^a   Kindl, Sandra ^b   Viglio, Alessandra ^a   Berti, Emilio ^d   Leithäuser, Frank ^a   Locatelli, Franco ^d   Gianelli, Umberto ^a   Beluffi, Giampiero ^a   Feller, Alfred C ^d   Borroni, Giovanni ^a   Magrini, Umberto ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Ospedale Civile   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d NONE

Author keywords

CD56 NCAM antigen; Extranodal CD30+ lymphomas; Immunohistochemistry

Indexed keywords

CD30 ANTIGEN; CD56 ANTIGEN; NERVE CELL ADHESION MOLECULE;

ARTICLE; CASE REPORT; CHILD; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; HEMATOPOIETIC CELL; HUMAN; KILLER CELL; LYMPHOCYTE ACTIVATION; LYMPHOMA; NOSE MUCOSA; PRIORITY JOURNAL; REED STERNBERG CELL; TUMOR LOCALIZATION;

ALKALINE PHOSPHATASE; ANTIGENS, CD56; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CA-15-3 ANTIGEN; CHILD, PRESCHOOL; COLORING AGENTS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; KILLER CELLS, NATURAL; LYMPHOMA, LARGE-CELL, KI-1; NEURAL CELL ADHESION MOLECULES; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; REMISSION INDUCTION; SKIN NEOPLASMS; T-LYMPHOCYTES;

EID: 0030663580     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199708000-00011     Document Type: Article

References (33)

1. Stein H, Mason DY, Gerdes J, et al. The expression of Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985;66:848-58.
2. Piris M, Brown DC, Gatter KC, Mason DY. CD30 expression in non-Hodgkin's lymphoma. Histopathology 1990;17:211-8.
3. Kadin ME. The spectrum of Ki-1+ cutaneous lymphomas. Curr Probl Dermatol 1990;19:132-43.
4. Willemze R, Beljaards R. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders: a proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 1993;28:973-80.
5. Paulli M, Berti E, Rosso R, et al. CD30/Ki-1 positive lymphoproliferative disorders of the skin. Clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. J Clin Oncol 1995;13:1343-54.
6. Beljaards RC, Kaudewitz P, Berti E, et al. Primary cutaneous CD30 positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favourable prognosis: a European multicenter study on 47 patients. Cancer 1993;71:2097-104.
7. Reiter A, Schrappe M, Tiemann M, et al. Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster Group studies. J Clin Oncol 1994;12:899-908.
8. Hercend T, Schmidt RE. Characteristics and uses of natural killer cells. Immunol Today 1988;9:291-3.
9. Ng CS, Chan JKC, Lo STH. Expression of natural killer cell markers in non-Hodgkin's lymphomas. Hum Pathol 1987;18:1257-62.
10. Wong KF, Chan JKC, Ng CS, Lee KC, Tsang WYW, Cheung MMC. CD56 (NKH1) positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. Hum Pathol 1992;23:798-804.
11. Jaffe SE, Chan JKC, Su I, Frizzera G, Mori S, Feller AC, Ho FC. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas, definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996;20:103-11.
12. Nakamura S, Suchi T, Koshikawa T, et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 1995;19:284-96.
13. Akamatsu M, Takeshita M, Ohshima K, Kikuchi M, Suzumiya J. Analysis of adhesion molecules in Ki-1 anaplastic large-cell lymphoma. Virchows Arch 1994;39:425-33.
14. McCarthy KP, Sloane JP, Kabarowski JHS, Matutes E, Wiedemann LM. A simplified method of detection of clonal rearrangements of the T-cell receptor-γ chain gene. Diagn Mol Pathol 1992;1:173-9.
15. Bourguin A, Tung R, Galili N, Sklar J. Rapid non radioactive detection of clonal T-cell receptor gene rearrangements in lymphoid neoplasms. Proc Natl Acad Sci USA 1990;87:8536-40.
16. Gordon BG, Weisenburger DD, Warkentin PI, et al. Peripheral T-cell lymphoma in childhood and adolescence: a clinicopathologic study of 22 patients. Cancer 1993:71:257-63.
17. Chan JKC, Buchanam R, Fletcher CDM. Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma. Am J Surg Pathol 1990;14:983-8.
18. Pileri S, Falini B, Delsol G, et al. Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1+ with a high content of reactive histiocytes). Histopathology 1990;16:383-91.
19. Kinney MC, Collins RD, Greer JP, Whitlock JA, Sioutos N, Kadin ME. A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg Pathol 1993;17:859-68.
20. Lennert K, Feller AC. Histopathologie der Non-Hodgkin-Lymphome. Heidelberg: Springer Verlag, 1990.
21. Imamura N, Kusunoki Y, Kawa-Ha K, et al. Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature: possible existence of a new clinical entity originating from the third lineage of lymphoid cells. Br J Haematol 1990;75:49-59.
22. Kern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 1992;79:2432-7.
23. Head DR, Kjeldsberg CR, Kadin ME, et al. Childhood T-cell malignancy resembling adult T-cell leukemia/lymphoma. Hematol Pathol 1987;1:15-25.
24. Zaatari GS, Chan WC, Kim TH, Williams DL, Kletzel M. Mulignant lymphoma of the skin in children. Cancer 1987;59:1040-5.
25. Greer JP, Kinney MC, Collins RD, et al. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol 1991;9:539-47.
26. Sun T, Schulman P, Kolitz J, et al. A study of lymphoma of large granular lymphocytes with modern modalities: report of two cases and review of the literature. Am J Hematol 1992;40:135-45.
27. Williams AF, Barclay AN. The immunoglobulin superfamily-domains for cell surface recognition. Annu Rev Immunol 1988;6:381-405.
28. Van Camp B, Durie BGM, Spier C, et al. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu 19). Blood 1990;76:377-82.
29. De Bruin PC, Beljaards RC, van Heerde P, et al. Differences in clinical behavior and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T cell or null cell phenotype. Histopathology 1993;23:127-35.
30. Agematsu K, Takeuchi S, Ichikawa M, et al. Spontaneous production of interleukin-6 by Ki-1 positive large cell anaplastic lymphoma with extensive bone destruction. Blood 1991;77:2299-301.
31. Chan JKC, Ng CS, Hui PK, et al. Anaplastic large cell Ki-1 lymphoma of bone. Cancer 1991;68:2186-91.
32. Ishizawa M, Okabe H, Matsumoto K, Hukuda S, Hodohara K, Ota S. Anaplastic large cell Ki-1 lymphoma with bone involvement: report of two cases. Virchows Arch 1995;427:105-10.
33. Nishihira H, Tanaka Y, Kigasawa H, Sasaki Y, Fujimoto J. Ki-1 lymphoma producing G-CSF. Br J Haematol 1991;80:556-7.